X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Complex Regional Pain Syndrome (CRPS) Companies

This report lists the top Complex Regional Pain Syndrome (CRPS) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Complex Regional Pain Syndrome (CRPS) industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Complex Regional Pain Syndrome (CRPS) Top Companies

  1. Boston Scientific

  2. Medtronic

  3. Johnson & Johnson

  4. Abbott Laboratories

  5. Nevro

*Disclaimer: Top companies sorted in no particular order

Complex Regional Pain Syndrome (CRPS) Market Major Players

Complex Regional Pain Syndrome (CRPS) Market Concentration

Complex Regional Pain Syndrome (CRPS)  Market Concentration

Complex Regional Pain Syndrome (CRPS) Company List

                            • Abbott

                            • Boston Scientific Corporation

                            • GSK plc

                            • ICU Medical

                            • Johnson & Johnson Services, Inc.

                            • Medtronic

                            • Viatris Inc

                            • Nevro Corp.

                            • Purdue Pharma

                            • Soin Therapeutics LLC (JanOne Inc.)

                            • PharmaTher Holdings Ltd.

                            • Sanofi


                        Specific to Complex Regional Pain Syndrome (CRPS) Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Complex Regional Pain Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)